chloroquine and isoniazid

chloroquine has been researched along with isoniazid in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-199011 (21.57)18.7374
1990's3 (5.88)18.2507
2000's7 (13.73)29.6817
2010's25 (49.02)24.3611
2020's5 (9.80)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gerena, L; Milhous, WK; Opsenica, D; Pocsfalvi, G; Solaja, BA; Terzić, N; Tinant, B1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Brun, R; Franzblau, SG; Huang, Q; Kozikowski, AP; Mao, J; Wan, B; Wang, Y1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chibale, K; Franzblau, SG; Guantai, EM; Gut, J; Hans, RH; Lategan, C; Rosenthal, PJ; Smith, PJ; Wan, B1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Ajay, A; Chaturvedi, V; Dubey, D; Gunjan, S; Pandey, S; Ramchandran, R; Singh, BN; Singh, S; Singh, V; Sinha, SK; Tripathi, R; Tripathi, RP1
Barazarte, A; Camacho, J; Charris, J; Gamboa, N; Gilman, R; Rodrigues, J; Rojas, R; Vaisberg, A1
Chibale, K; Franzblau, SG; Gut, J; Hans, RH; Rosenthal, PJ; van Helden, PD; Wan, B; Wiid, IJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Boshoff, HI; Boyd, PD; Copp, BR; Kaiser, M; McCracken, ST1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chaturvedi, V; Chauhan, K; Chauhan, PM; Puri, SK; Saxena, J; Saxena, JK; Sharma, M; Singh, SV; Srivastava, K; Trivedi, P1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Kalaria, PN; Raval, DK; Satasia, SP1
Karad, SC; Purohit, VB; Raval, DK1
Brantner, A; Brun, R; Bucar, F; Faist, J; Gröblacher, B; Kaiser, M; Kalia, Y; Merino, V; Perozzo, R; Saf, R; Scapozza, L; Seebacher, W; Weis, R; Wolkinger, V1
Bharate, SB; Khan, IA; Khan, SI; Singh, S; Vishwakarma, RA; Yadav, RR1
Avilés, E; Chandrasena, K; Franzblau, SG; Le Roch, KG; Mayer, AM; Prudhomme, J; Rodríguez, AD1
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Sankar, C; Umamatheswari, S1
Alajlani, M; Bauer, R; Belaj, F; Brantner, A; Bucar, F; Faist, J; Hochegger, P; Kaiser, M; Kretschmer, N; Mäser, P; Mohsin, NU; Saf, R; Seebacher, W; Turek, I; Weis, R1
Caljon, G; Cos, P; Courtens, C; Martin, A; Risseeuw, M; Van Calenbergh, S1
Caljon, G; Cos, P; Courtens, C; Maes, L; Martin, A; Risseeuw, M; Van Calenbergh, S1
Bucar, F; Kaiser, M; Kalt, MM; Ochensberger, S; Presser, A; Saf, R; Schuehly, W; Solnier, J1
Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD1
Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C1
Bazyka, DA1
Crowle, AJ; Dahl, R; May, MH; Ross, E1
Crowle, AJ; May, MH1
Chinje, CE; Emerole, GO; Garba, MA; Mgbojikwe, LO; Nwankwo, JO1
Tiess, D1
Wurm, K1
Johansson, B1
Bourn, WM; Chin, L; Laird, HE; Picchioni, AL1
Holmes, J; Sapeika, N; Zwarenstein, H1
Jackson, EA; McLeod, DC1
Vischer, WA1
Havel, A; Rosenfeld, M1
Ozawa, K; Shichijo, K; Takemura, Y; Yamada, T1
SPILLANE, JD1
Andreoni, F; Dal Molin, M; Matt, U; Nemeth, J; Sander, P; Schilcher, K; Selchow, P; Sharif, O; Stenzinger, A; Strommer, S; Zeitlinger, M; Zinkernagel, AS1
Calender, A; Israel-Biet, D; Pacheco, Y; Valeyre, D1
Buchwald, A; Divala, T; Laufer, MK; Laurens, MB; Mallewa, J; Mategula, D; Milanzi, E; Mungwira, R; Mwapasa, V; Nampota, N; Tsirizani-Galileya, L; Van Oosterhout, JJ1

Reviews

4 review(s) available for chloroquine and isoniazid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Therapy of sarcoidosis].
    Archiv fur klinische und experimentelle Dermatologie, 1966, Volume: 227, Issue:1

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Chloroquine; Drug-Related Side Effects and Adverse Reactions; Humans; Isoniazid; Male; Sarcoidosis; Vitamin E

1966
[Side effects of drugs. 4. Drug induced polyneuropathies and myopathies].
    Lakartidningen, 1969, Dec-15, Volume: 66

    Topics: Adrenocorticotropic Hormone; Chloroquine; Glucocorticoids; Humans; Hydralazine; Isoniazid; Muscular Diseases; Neurons, Afferent; Nitrofurans; Peripheral Nervous System Diseases; Thalidomide; Vincristine

1969
Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
    Trends in immunology, 2020, Volume: 41, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Autophagy; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Host-Pathogen Interactions; Humans; Isoniazid; Lung; Pandemics; Pneumonia, Viral; Pulmonary Edema; Rifampin; Sarcoidosis; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severity of Illness Index

2020

Trials

2 trial(s) available for chloroquine and isoniazid

ArticleYear
[Comparative results of treating lichen ruber planus by various methods].
    Vestnik dermatologii i venerologii, 1977, Issue:2

    Topics: Adolescent; Adult; Aged; Aspirin; Bismuth; Child; Child, Preschool; Chloroquine; Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Griseofulvin; Humans; Isoniazid; Lichen Planus; Male; Middle Aged; Prednisolone

1977
Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study.
    Medicine, 2022, Sep-30, Volume: 101, Issue:39

    Topics: Adult; Antitubercular Agents; Chloroquine; Cohort Studies; HIV Infections; Humans; Isoniazid; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination

2022

Other Studies

45 other study(ies) available for chloroquine and isoniazid

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity.
    Journal of medicinal chemistry, 2002, Aug-01, Volume: 45, Issue:16

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Chlorocebus aethiops; Crystallography, X-Ray; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization; Spiro Compounds; Steroids; Structure-Activity Relationship; Vero Cells

2002
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
    Journal of medicinal chemistry, 2009, Nov-12, Volume: 52, Issue:21

    Topics: Antimalarials; Antitubercular Agents; Benzothiazoles; Drug Design; Isoxazoles; Models, Molecular; Mycobacterium tuberculosis; Phenylacetates; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones.
    Bioorganic & medicinal chemistry letters, 2010, Feb-01, Volume: 20, Issue:3

    Topics: Alkynes; Antimalarials; Antitubercular Agents; Chalcones; Mycobacterium tuberculosis; Plasmodium falciparum

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents.
    Bioorganic & medicinal chemistry, 2010, Dec-01, Volume: 18, Issue:23

    Topics: Animals; Antimalarials; Antitubercular Agents; Binding Sites; Chalcones; Chlorocebus aethiops; Computer Simulation; Cyclopropanes; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells

2010
Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents.
    Bioorganic & medicinal chemistry, 2011, Mar-15, Volume: 19, Issue:6

    Topics: Animals; Antimalarials; Antitubercular Agents; Benzimidazoles; Cell Line, Tumor; Drug Resistance, Multiple; Hemin; Hemoglobins; Humans; Hydrazines; Hydrolysis; Mice; Plasmodium

2011
Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents.
    Bioorganic & medicinal chemistry letters, 2011, Apr-01, Volume: 21, Issue:7

    Topics: Animals; Antimalarials; Antitubercular Agents; Isatin; Lactones; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.
    Bioorganic & medicinal chemistry, 2012, Feb-15, Volume: 20, Issue:4

    Topics: Antimalarials; Antitubercular Agents; Coumarins; Dimerization; Fatty Acids, Monounsaturated; Inhibitory Concentration 50; Leishmania donovani; Light; Molecular Structure; Plasmodium falciparum; Pyrones

2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents.
    European journal of medicinal chemistry, 2013, Volume: 62

    Topics: Aminoquinolines; Animals; Anti-Infective Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Rhodanine; Structure-Activity Relationship; Vero Cells

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
    European journal of medicinal chemistry, 2014, May-06, Volume: 78

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship

2014
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship

2014
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
    Bioorganic & medicinal chemistry letters, 2015, Apr-01, Volume: 25, Issue:7

    Topics: Administration, Oral; Animals; Antiprotozoal Agents; Azabicyclo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship; Tissue Distribution; Trypanosoma brucei rhodesiense; Trypanosomiasis, African

2015
Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
    European journal of medicinal chemistry, 2015, Jun-15, Volume: 98

    Topics: Animals; Antimalarials; Antitubercular Agents; Cell Line, Tumor; Humans; Indoles; Inhibitory Concentration 50; Plasmodium falciparum; Pyrimidines; Quantitative Structure-Activity Relationship; Sulfonamides

2015
Synthesis and preliminary biological evaluation of a small library of hybrid compounds based on Ugi isocyanide multicomponent reactions with a marine natural product scaffold.
    Bioorganic & medicinal chemistry letters, 2015, Nov-15, Volume: 25, Issue:22

    Topics: Amines; Anti-Inflammatory Agents; Cyanides; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Small Molecule Libraries

2015
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
    European journal of medicinal chemistry, 2016, Apr-13, Volume: 112

    Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis

2016
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
    Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3

    Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines

2017
Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Benzyl Compounds; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridines; Quaternary Ammonium Compounds; Rats; Saccharomyces cerevisiae; Salts; Structure-Activity Relationship; Trypanosoma brucei rhodesiense

2018
Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
    Bioorganic & medicinal chemistry letters, 2019, 05-01, Volume: 29, Issue:9

    Topics: Antimalarials; Antitubercular Agents; Cell Line; Cell Survival; Fosfomycin; Humans; Hydroxamic Acids; Mycobacterium tuberculosis; Organophosphonates; Plasmodium falciparum; Prodrugs

2019
Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
    Bioorganic & medicinal chemistry letters, 2019, 05-15, Volume: 29, Issue:10

    Topics: Antimalarials; Antitubercular Agents; Carbamates; Drug Evaluation, Preclinical; Fosfomycin; Humans; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Plasmodium falciparum; Prodrugs; Signal Transduction; Structure-Activity Relationship

2019
Palladium-catalysed synthesis of arylnaphthoquinones as antiprotozoal and antimycobacterial agents.
    European journal of medicinal chemistry, 2020, Dec-01, Volume: 207

    Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Catalysis; Chemistry Techniques, Synthetic; Mycobacterium smegmatis; Palladium; Plasmodium falciparum; Quinones; Trypanosoma brucei rhodesiense

2020
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
    Bioorganic & medicinal chemistry letters, 2021, 03-15, Volume: 36

    Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci

2021
Antimicrobial and Cytotoxic Angucyclic Quinones from
    Journal of natural products, 2021, 11-26, Volume: 84, Issue:11

    Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones

2021
Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic.
    Infection and immunity, 1991, Volume: 59, Issue:5

    Topics: Ammonium Chloride; Cell Fusion; Cells, Cultured; Chloroquine; Humans; Hydrogen-Ion Concentration; Isoniazid; Macrophages; Mycobacterium avium; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Virulence

1991
Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:11

    Topics: Adult; Calcifediol; Calcitriol; Chloroquine; Culture Media; Female; Humans; In Vitro Techniques; Isoniazid; Macrophages; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin

1990
Possible chloroquine-induced modification of N-acetylation of isoniazid and sulphadimidine in the rat.
    Biochemical pharmacology, 1990, Aug-01, Volume: 40, Issue:3

    Topics: Acetylation; Animals; Arylamine N-Acetyltransferase; Chemical Phenomena; Chemistry; Chloroquine; Female; Isoniazid; Liver; Male; Molecular Structure; Rats; Rats, Inbred Strains; Sulfamethazine

1990
[Rapid UV-spectrophotometric determination of toxic materials in samples of stomach contents, with special reference to the relatively less common organic poisons].
    Zeitschrift fur klinische Chemie und klinische Biochemie, 1969, Volume: 7, Issue:6

    Topics: Adult; Aged; Anticonvulsants; Barbiturates; Benzalkonium Compounds; Chemistry, Clinical; Chloroquine; Cholinesterase Inhibitors; Colchicine; Forensic Medicine; Humans; Isoniazid; Methaqualone; Middle Aged; Niacinamide; Nicotine; Oils; Poisons; Promazine; Pyridines; Spectrophotometry; Stomach; Ultraviolet Rays

1969
Optimal antidotal dose of activated charcoal.
    Toxicology and applied pharmacology, 1973, Volume: 26, Issue:1

    Topics: Animals; Antidotes; Charcoal; Chloroquine; Intestinal Absorption; Isoniazid; Male; Pentobarbital; Rats; Time Factors

1973
Inhibitory effect of some quinoline, phthalazine, and coumarin derivatives on glucose-6-phosphate dehydrogenase in vitro.
    Research communications in chemical pathology and pharmacology, 1973, Volume: 6, Issue:2

    Topics: Binding, Competitive; Chloroquine; Coumarins; Glucosephosphate Dehydrogenase; Heterocyclic Compounds; Hydralazine; Isoniazid; Novobiocin; Phenazines; Phenelzine; Phenylhydrazines; Probenecid; Pyridines; Quinacrine; Quinidine; Quinine; Quinolines; Sulfanilamides; Warfarin; Yeasts

1973
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
    American journal of hospital pharmacy, 1974, Volume: 31, Issue:2

    Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin

1974
Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10-(p-chlorphenyl-2,10-dihydro-2-(isopropylimino)-phenazine (G 30'320, B. 663).
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:5

    Topics: Animals; Antitubercular Agents; Aspergillosis; Candidiasis; Chloroquine; Cricetinae; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Escherichia coli Infections; Female; Isoniazid; Klebsiella Infections; Leprosy; Listeriosis; Malaria; Mice; Mycobacterium Infections; Mycobacterium tuberculosis; Mycoses; Nitrofurans; Nocardia Infections; Oils; Phenazines; Pneumococcal Infections; Rats; Staphylococcal Infections; Stimulation, Chemical; Streptococcal Infections; Surface-Active Agents; Time Factors; Tinea; Toxoplasmosis, Animal; Trypanosomiasis; Tuberculosis

1970
[Inhibition of isoniazid activity in the presence of chloroquinum diphosphoricum].
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:9

    Topics: Animals; Body Weight; Chloroquine; Depression, Chemical; Drug Antagonism; Isoniazid; Mice; Mycobacterium tuberculosis; Tuberculosis

1970
Comparison of the effects of several drugs on tissue uptake of labeled thyroxine and triiodothyronine in the presence of rat plasma in vitro.
    Metabolism: clinical and experimental, 1966, Volume: 15, Issue:8

    Topics: Animals; Chloroquine; Coloring Agents; Dinitrophenols; In Vitro Techniques; Isoniazid; Liver; Methylene Blue; Muscles; Novobiocin; Pituitary Gland; Quinine; Rats; Rose Bengal; Salicylates; Surface-Active Agents; Thyroxine; Triiodothyronine; Trypan Blue

1966
IATROGENIC NEUROLOGICAL DISEASES. DRUG-INDUCED NEUROLOGICAL DISORDERS.
    Proceedings of the Royal Society of Medicine, 1964, Volume: 57

    Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antihypertensive Agents; Brain Diseases; Chloroquine; Cranial Nerves; Drug Hypersensitivity; Drug Therapy; Iatrogenic Disease; Isoniazid; Muscular Diseases; Neurologic Manifestations; Nitrofurantoin; Peripheral Nervous System Diseases; Retina; Seizures; Streptomycin; Toxicology; Tranquilizing Agents; Vertigo

1964
Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:1

    Topics: Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Chloroquine; Drug Synergism; Humans; Isoniazid; Macrophages; Mycobacterium tuberculosis; Neoplasm Proteins; Pyrazinamide; THP-1 Cells

2017